NCT06026189View on ClinicalTrials.gov

Safely Reduce Cystoscopic Evaluations for Hematuria Patients

NARecruitingINTERVENTIONAL
Enrollment

1,100

Participants

Timeline

Start Date

May 31, 2023

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2027

Conditions
HematuriaUrothelial NeoplasmUrothelial CarcinomaBladder Cancer
Interventions
DIAGNOSTIC_TEST

urine-first strategy

Only patients with an abnormal urine test result undergo a diagnostic workup, i.e. cystoscopy and upper-tract imaging.

Trial Locations (1)

3015GD

RECRUITING

SeARCH-trial Pijpers, Rotterdam

Sponsors
All Listed Sponsors
lead

Erasmus Medical Center

OTHER

NCT06026189 - Safely Reduce Cystoscopic Evaluations for Hematuria Patients | Biotech Hunter | Biotech Hunter